Swami Institute of Pharmacy, Abhona, Nashik, Maharashtra, India 423502
Transdermal Drug Delivery Systems (TDDS) have emerged as a promising alternative to conventional drug administration routes by enabling the delivery of therapeutic agents across the skin into systemic circulation. These systems offer advantages such as avoidance of first-pass metabolism, controlled drug release, improved patient compliance, and reduced side effects. However, the skin’s barrier function—primarily the stratum corneum—limits drug permeation. Recent advancements including microneedles, nanotechnology-based carriers, iontophoresis, electroporation, and smart polymers have significantly improved the efficiency of TDDS. This review provides an in-depth discussion of skin anatomy, mechanisms of drug permeation, types of TDDS, formulation components, evaluation methods, recent technological advancements, therapeutic applications, limitations, and future perspectives.
Drug delivery systems are designed to achieve optimal therapeutic outcomes by delivering drugs at the right site, time, and concentration. Traditional routes like oral and parenteral administration often suffer from drawbacks such as poor bioavailability, gastrointestinal degradation, and patient non-compliance.
Transdermal drug delivery systems (TDDS) are defined as self-contained, discrete dosage forms that deliver drugs through the skin at a controlled rate into systemic circulation. Since the approval of the first transdermal patch (scopolamine), TDDS has gained significant attention in pharmaceutical research.
2. Anatomy and Physiology of Skin
2.1 Structure of Skin
The skin is the largest organ of the human body and acts as a protective barrier. It consists of three main layers:
2.1.1 Epidermis
The stratum corneum consists of dead keratinized cells embedded in lipid matrix (brick-and-mortar model).
2.1.2 Dermis
2.1.3 Hypodermis
2.2 Barrier Function of Skin
The primary barrier is the stratum corneum, which restricts entry of:
3. Mechanism of Drug Permeation
Drugs penetrate the skin via three major pathways:
3.1 Transcellular Route
3.2 Intercellular Route
3.3 Appendageal Route
3.4 Factors Affecting Drug Permeation
Physicochemical Factors
Biological Factors
4. Types of Transdermal Drug Delivery Systems
4.1 Passive Systems
Rely on diffusion mechanisms.
Types:
4.2 Active Systems
Use external energy to enhance permeation.
Types:
5. Components of TDDS
|
Component |
Function |
|
Drug |
Active ingredient |
|
Polymer matrix |
Controls drug release |
|
Permeation enhancer |
Improves skin penetration |
|
Adhesive |
Maintains patch contact |
|
Backing layer |
Protects system |
|
Release liner |
Removed before use |
6. Ideal Properties of Drugs for TDDS
7. Advantages of TDDS
8. Limitations of TDDS
9. Evaluation of TDDS
9.1 Physicochemical Evaluation
9.2 In-vitro Studies
9.3 In-vivo Studies
9.4 Stability Studies
10. Recent Advancements in TDDS
10.1 Microneedle Technology
Microneedles create microchannels in the skin.
Types:
Advantages:
10.2 Nanotechnology-Based Systems
|
Types |
Structure |
|
Liposome |
|
|
Niosomes |
|
|
Solid lipid nanoparticles |
|
|
Nanostructured lipid carriers |
|
Benefits:
10.3 Hydrogel Systems
10.4 Iontophoresis
10.5 Sonophoresis
10.6 Electroporation
10.7 Smart TDDS
11. Generations of TDDS
|
Generation |
Characteristics |
|
First |
Passive diffusion |
|
Second |
Chemical enhancers |
|
Third |
Microneedles, nanotech |
12. Applications of TDDS
12.1 Cardiovascular Diseases
12.2 Pain Management
12.3 Hormonal Therapy
12.4 Smoking Cessation
12.5 Vaccination
12.6 Diabetes
12.7 Neurological Disorders
12.8 Cosmetics
13. Regulatory Aspects
14. Future Perspectives
15. CONCLUSION
Transdermal drug delivery systems have revolutionized modern pharmaceutics by providing a non-invasive and controlled drug delivery method. Despite challenges such as limited permeability and drug selection constraints, recent advancements like microneedles and nanotechnology have expanded their applicability. Future developments are expected to make TDDS a key component in personalized and smart drug delivery systems.
REFERENCES
Deore Harshal, Shirsath Aastha, Advancements and Applications of Transdermal Drug Delivery Systems (TDDS), Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 3986-3992. https://doi.org/10.5281/zenodo.20229383
10.5281/zenodo.20229383
